-
1 Comment
Integra LifeSciences Holdings Corporation is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
Integra LifeSciences Holdings Corporation's total revenue sank by 1.6% to $389M since the same quarter in the previous year.
Its net income has increased by 505.4% to $93M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.2% to $72M since the same quarter in the previous year.
Based on the above factors, Integra LifeSciences Holdings Corporation gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | US4579852082 |
| Industry | Medical Devices |
| Beta | 1.02 |
|---|---|
| Market Cap | 683M |
| PE Ratio | None |
| Target Price | 77.7 |
| Dividend Yield | None |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IL3.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026